跳至主要内容
临床试验/NCT05909020
NCT05909020招募中不适用

EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head and Neck Cancer Referral Pathway (Phase 1)

Royal Marsden NHS Foundation Trust4 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2023年3月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
165
试验地点
4
主要终点
Inventory and specification for the SYmptom iNput Clinical (SYNC) system

研究概览

简要总结

Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway?

Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.

详细描述

The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC diagnostic pathways and what patients and clinicians value in these. The language used within the EVEREST pathway needs to be accessible and optimal to elicit appropriate information.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC
  • Participants willing and able to give informed consent for participation in the study.
  • Clinicians:
  • Staff at participating sites involved in the diagnostic pathway for people with suspected HNC.

排除标准

  • Individuals who do not meet the inclusion criteria.

结局指标

主要结局

Inventory and specification for the SYmptom iNput Clinical (SYNC) system

时间窗: September 2022 - August 2023

To optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system

次要结局

  • To further explore the current suspected HNC pathway and the language used when discussing symptoms.(September 2022 - August 2023)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验